What You Should Know:
- The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC's oncology care clinicians.
- The strategic collaboration equips clinicians at MUSC Hollings Cancer Center with Flatiron Assist, a unique clinical decision support platform designed specifically for oncology. Flatiron Assist prioritizes the latest
Read More
real-world data (RWD)
Trilliant Health Launches Network Explorer: An Application To Improve Network Performance With Real-World Data
What You Should Know:
Trilliant Health, the leading provider of data-driven strategy analytics for the health economy, announced the launch of Network Explorer, a point-and-click application to manage network performance.Network Explorer enables stakeholders across the health economy to form evidence-based strategies to improve their network performance. Limited to their own data, no health economy stakeholder has a full picture of the scope of physician-patient interactions, leaving
Read More
CDC Awards Truveta Real-World Data Contract to Study COVID, Maternal Health, Pediatric Care
What You Should Know:
- Truveta, a consortium of 30 health systems united in "Saving Lives with Data," has secured a significant partnership with the U.S. Centers for Disease Control and Prevention (CDC).
- This collaboration will leverage Truveta's vast repository of real-world healthcare data to empower CDC researchers in tackling pressing public health challenges, including COVID-19, maternal health, and pediatric care.
Unprecedented Data Access for COVID-19 Insights
Truveta will
Read More
Leveraging RWD & Tech: Diversifying Clinical Research for Real-World Impact
In today's complex healthcare landscape, real-world data (RWD) is increasingly valued for its information regarding diverse patient populations. Clinical research sites are an essential part of the RWD collection process, which increasingly leverages advanced technologies that enhance data collection, analysis and informed decision-making.
RWD can accelerate development timelines and augment clinical trial insights with key observational results from a wider and more diverse range of
Read More
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
What You Should Know:
- ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
- This strategic move will significantly enhance and expand CancerLinQ's capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research.
CancerLinQ Background
CancerLinQ represents one of the largest oncology
Read More
Syapse and FDA OCE Collaborate to Advance Real-World Evidence in Oncology
What You Should Know:
- Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement.
- This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More
Veradigm Invests $30M in Behavioral Health Co. Holmusk
What You Should Know:
- Veradigm Inc. (NASDAQ: MDRX), a provider of healthcare data and technology solutions, announced it has made a $30M strategic investment in Holmusk, a global behavioral health real-world evidence company. The strategic investment builds on the strengths of each company to fuel innovation in behavioral health and create the evidence needed to move the field forward.
- In this new phase of the collaboration, cohorts of millions of behavioral
Read More
Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis.Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate
Read More
COTA Launches EHR Dataset to Advance Generative AI Models for Cancer Care
What You Should Know:
- COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer care.
- Vista will provide biopharmaceutical companies with timely insights from real-world data sources to bring life-saving therapies to market faster. Vista uses automated data abstraction techniques, machine learning algorithms, and medical expert
Read More
Atropos Health Goes Global With New Funding from Samsung, Presido Ventures
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced that it has completed strategic financing from Presidio Ventures, the venture arm of Sumitomo Corporation, Samsung Next, a venture arm of Samsung Electronics, Gaingels, and others.The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S., using its proprietary technology and approach. The
Read More
